Heidelberg Engineering GmbH

3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionize monitoring of kidney disease, which often progresses without symptoms in the early stages. Experts say the technology has potential to support early diagnosis as current screening tests cannot detect the condition until half of the kidney function has been lost. 3D eye scans can reveal vital clues about kidney health that could help to track the progression of disease, research suggests. The advance could revolutionise monitoring of kidney disease, which often progresses without symptoms in the early stages. Experts say the technology has potential to support early diagnosis as current screening tests cannot detect the condition until half of the kidney function has been lost. Researchers used highly-magnified images to detect changes to the retina -- the layer of tissue at the back of the eye that senses light and sends signals to the brain. They found that the images offer a quick, non-invasive way to monitor kidney health. The eye is the only part of the body where it is possible to view a key process called microvascular circulation -- and this flow of blood through the body's tiniest vessels is often affected in kidney disease. Researchers at the University of Edinburgh investigated whether 3D images of the retina, taken using a technology called optical coherence tomography (OCT), could be used to identify and accurately predict the progression of kidney disease. OCT scanners -- used in most high street opticians -- use light waves to create a cross-sectional picture of the retina, displaying each individual layer, within a few minutes. The team looked at OCT images from 204 patients at different stages of kidney disease, including transplant patients, alongside 86 healthy volunteers. They found that patients with chronic kidney disease had thinner retinas compared with healthy volunteers. The study also showed that thinning of the retina progressed as kidney function declined. These changes were reversed when kidney function was restored following a successful transplant. Patients with the most severe form of the disease, who received a kidney transplant, experienced rapid thickening of their retinas after surgery. More people than ever are at risk of kidney disease, which is often caused by other conditions that put a strain on the kidneys, including diabetes, high blood pressure and obesity. With further research, regular eye checks could one day aid early detection and monitoring to prevent the disease from progressing. It could also allow patients to make lifestyle changes that reduce the risk of health complications, experts say. The technology, supported by Heidelberg Engineering's imaging platform, could also aid the development of new drugs, the research team says. It could do so by measuring changes in the retina that indicate whether -- and in what way -- the kidney responds to potential new treatments. The researchers say further studies -- including longer-term clinical trials in larger groups of patients -- are needed before the technology can be routinely used. An estimated 7.2million people in the UK live with chronic kidney disease -- more than 10% of the population. It costs the NHS around £7billion each year. The study is published in Nature Communications. It was funded by Kidney Research UK, and supported by Edinburgh Innovations, the University's commercialisation service.

The upgradeable platform is said to combine biometry, IOL power calculation with corneal topography and tomography, anterior chamber metrics, and imaging to help transform the daily clinical routine A screengrab from all the apps of ANTERION platform. (Credit: Business Wire) US-based Heidelberg Engineering has received the US Food and Drug Administration (FDA) approval for its all-in-one anterior segment diagnostics platform, ANTERION platform. The company has designed the ANTERION platform to streamline practice workflow. The upgradeable platform combines biometry, IOL power calculation with corneal topography and tomography, anterior chamber metrics, and imaging to help transform the daily clinical routine. According to Heidelberg, ANTERION has additional proprietary features like patented eye tracking and composite imaging technologies that help deliver Heidelberg image quality. This allows professionals in the eye care industry to perform anterior segment examinations and obtain key measurements through swept-source optical coherence tomography (OCT) images that support clinical decision-making and boost diagnostic confidence, the ophthalmic imaging company said. Heidelberg Engineering managing director Arianna Vargas said: “Building upon our previous CE-marking, we are thrilled that the ANTERION platform is now available to eye care providers across the US. “We believe this device complements our current portfolio of products and arms anterior segment-focused practices with the comprehensive data needed to support diagnostic decisions that ultimately improve patient care.” The Imaging App, which received the FDA approval in November 2021, is central to the ANTERION platform. The anterior segment is the centre of the Imaging App’s visualisation, which produces revealing OCT pictures that help eye professionals diagnose and treat anterior segment changes. ANTERION’s functionality is now expanded with the recently FDA-cleared apps that were created to address a range of therapeutic demands. The list includes the Cataract App which combines key measurements for cataract surgery planning, including toric IOL calculators and integrated monofocal. The Cornea App offers a complete range of corneal measures to measure each patient’s unique corneal geometry. These diagnostic insights can be used to guide surgical planning and refractive technique evaluation. Lastly, the Metrics App has swept-source OCT images with the anterior chamber in a radial view. It enables predefined angle parameter calculations and free-hand measurements.

DUBLIN, July 10, 2023 /PRNewswire/ --The "Optical Imaging Techniques: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Optical Imaging Techniques estimated at US$1.9 Billion in the year 2022, is projected to reach a revised size of US$4.1 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2022-2030.Optical Coherence Tomography, one of the segments analyzed in the report, is projected to record a 10.1% CAGR and reach US$3.2 Billion by the end of the analysis period.Taking into account the ongoing post pandemic recovery, growth in the Hyperspectral Imaging segment is readjusted to a revised 10.2% CAGR for the next 8-year period. The U.S. Market is Estimated at $890.6 Million, While China is Forecast to Grow at 14.3% CAGR The Optical Imaging Techniques market in the U.S. is estimated at US$890.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$328.6 Million by the year 2030 trailing a CAGR of 14.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 9.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$286.6 Million by the year 2030. Select Competitors (Total 42 Featured) - Abbott Laboratories Agfa-Gevaert Group ASE Optics Europe Canon U.S.A., Inc. Carl-Zeiss Meditec AG ChemImage Corporation Cytoviva Inc. Headwall Photonics, Inc. Heidelberg Engineering GmbH Koninklijke Philips N.V. Leica Microsystems GmbH Optical Imaging Ltd. PerkinElmer, Inc. Topcon Corporation Key Topics Covered: I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession An Introduction to Optical Imaging Optical Imaging: Current Market Scenario and Outlook Developed Regions: Dominant Consumers of Optical Imaging Technologies World Optical Imaging Market by Region: Percentage Breakdown of Revenues for Developed and Developing Regions (2019 & 2025) Developing Regions to Spearhead Future Growth World Optical Imaging Market - Geographic Regions Ranked by CAGR (Value) for 2018-2025: China, Asia-Pacific, Latin America, Middle East, Africa, Canada, USA, Europe, and Japan Key Factors Driving Demand for Medical Imaging Services in Developing Regions Growing Healthcare Awareness Increased Access to Healthcare and Surge in Number of Hospitals & Clinics Proliferation of Medical Tourism Optical Coherence Tomography: Major Optical Imaging Technique Robust Opportunities for Hyperspectral Imaging Near-infrared Spectroscopy Gains Traction Photoacoustic Tomography Set to Make Gains Optical Imaging Techniques - Global Key Competitors Percentage Market Share in 2022 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Hospitals & Clinics: Dominant Consumers of Optical Imaging Solutions Optical Imaging Remains Highly Relevant in Research Laboratories Rising Prominence of Optical Imaging Technologies for Pharmaceutical & Biotech Firms Growing Investments in Healthcare & Lifescience Sectors Create Conducive Environment for Growth of Optical Imaging Market World Healthcare Spending & Growth (in US$ Trillion) and % Real GDP Growth for the Years 2012 through 2018 High Growth Opportunities in Oncology Care Worldwide Incidence of Cancer (2012, 2018 & 2040): Number of New Cases Diagnosed Growing Adoption in Cardiology Applications Bodes Well Demographic Factors Favor Growth Market Stands to Gain from Expanding Geriatric Population Global Aging Population (in Thousands) by Age Group: 1975-2050 Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) Life Expectancy at Birth in Years of People in Select Countries (2017) 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITION For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets